Skip Navigation
Skip to contents

Clin Endosc : Clinical Endoscopy

OPEN ACCESS

Author index

Page Path
HOME > Browse Articles > Author index
Search
Marisa DeGaetani 1 Article
Photodynamic Therapy in Unresectable Cholangiocarcinoma: Not for the Uncommitted
Jayant P. Talreja, Marisa DeGaetani, Kristi Ellen, Timothy Schmitt, Monica Gaidhane, Michel Kahaleh
Clin Endosc 2013;46(4):390-394.   Published online July 31, 2013
DOI: https://doi.org/10.5946/ce.2013.46.4.390
AbstractAbstract PDFPubReaderePub
Background/Aims

Photodynamic therapy (PDT) in unresectable cholangiocarcinoma has been associated with improved survival. We report a single tertiary care center experience over the past 6 years.

Methods

Fifty-five patients with unresectable cholangiocarcinoma received PDT between 2004 and 2010. Plastic stents were placed after PDT to prevent cholangitis.

Results

Twenty-seven patients (49%) showed Bismuth type IV, 22 (41%) showed Bismuth type III, and six (10%) showed Bismuth type I and II. Twenty patients (37%) received chemotherapy and radiation therapy, five (9%) received chemotherapy only; and one (2%) received radiation therapy only. Mean number of PDT sessions was 1.9±1.5 sessions (range, 1 to 9). Mean survival duration was 293±266 days (median, 190; range, 25 to 1,332). PDT related complications included three (5%) facial burn, three (5%) photosensitivity, and two (3%) rash. Kaplan-Meier analysis comparing the survival means of patients who received PDT and chemotherapy/radiation therapy (median survival 257 days; 95% confidence interval [CI], 166 to 528) versus who received PDT only (median survival 183 days; 95% CI, 129 to 224) showed no significant difference (log-rank p=0.20).

Conclusions

PDT has a measurable impact on survival in unresectable cholangiocarcinoma but requires aggressive stenting posttherapy.

Citations

Citations to this article as recorded by  
  • Ablation Therapy of the Biliary Tree
    Marina Kim, Darshan Parekh, Michel Kahaleh
    Journal of Clinical Gastroenterology.2024; 58(4): 317.     CrossRef
  • Ablative Therapy in Non-HCC Liver Malignancy
    Tyler P. Robinson, Travis Pebror, Matthew E. Krosin, Leonidas G. Koniaris
    Cancers.2023; 15(4): 1200.     CrossRef
  • Benefits and safety of photodynamic therapy in patients with hilar cholangiocarcinoma: A meta-analysis
    Pengcheng Chen, Ting Yang, Peidong Shi, Jiangbo Shen, Qingchun Feng, Jingen Su
    Photodiagnosis and Photodynamic Therapy.2022; 37: 102712.     CrossRef
  • Photodynamic Therapy (PDT), Radiofrequency Ablation (RFA) With Biliary Stents in Palliative Treatment of Unresectable Extrahepatic Cholangiocarcinoma
    Babu P. Mohan, Saurabh Chandan, Shahab R. Khan, Lena L. Kassab, Suresh Ponnada, Everson L.A. Artifon, Jose P. Otoch, Stephanie McDonough, Douglas G. Adler
    Journal of Clinical Gastroenterology.2022; 56(2): e153.     CrossRef
  • Comparing palliative treatment options for cholangiocarcinoma: photodynamic therapy vs. radiofrequency ablation
    Tayyaba Mohammad, Michel Kahaleh
    Clinical Endoscopy.2022; 55(3): 347.     CrossRef
  • New approach to the treatment of cancer of large duodenal papilla and extrahepatic bile ducts with photodynamic therapy
    E. P. Stranadko, A. V. Baranov, V. A. Duvansky, A. I. Lobakov, V. A. Morokhotov, M. V. Riabov
    Experimental and Clinical Gastroenterology.2022; (5): 78.     CrossRef
  • Endoscopic palliation of malignant biliary obstruction
    Andrew Canakis, Michel Kahaleh
    World Journal of Gastrointestinal Endoscopy.2022; 14(10): 581.     CrossRef
  • Endoscopic Retrograde Cholangiopancreatography-Guided Ablation for Cholangiocarcinoma
    Ross C.D. Buerlein, Andrew Y. Wang
    Gastrointestinal Endoscopy Clinics of North America.2019; 29(2): 351.     CrossRef
  • Photodynamic Therapy Plus Chemotherapy Compared with Photodynamic Therapy Alone in Hilar Nonresectable Cholangiocarcinoma
    Robert Wentrup, Nicola Winkelmann, Andrey Mitroshkin, Matthias Prager, Winfried Voderholzer, Guido Schachschal, Christian J, rgensen, Carsten B, ning
    Gut and Liver.2016;[Epub]     CrossRef
  • Efficacy and safety of photodynamic therapy for unresectable cholangiocarcinoma: A meta-analysis
    Yi Lu, Lei Liu, Jia-chuan Wu, Li-ke Bie, Biao Gong
    Clinics and Research in Hepatology and Gastroenterology.2015; 39(6): 718.     CrossRef
  • Biliary Tumor Ablation with Photodynamic Therapy and Radiofrequency Ablation
    Ioana Smith, Michel Kahaleh
    Gastrointestinal Endoscopy Clinics of North America.2015; 25(4): 793.     CrossRef
  • The Role of Endoscopy in the Diagnosis and Management of Cholangiocarcinoma
    Ajaypal Singh, Uzma D. Siddiqui
    Journal of Clinical Gastroenterology.2015; 49(9): 725.     CrossRef
  • Role of photodynamic therapy and intraductal radiofrequency ablation in cholangiocarcinoma
    Janaki Patel, Nada Rizk, Michel Kahaleh
    Best Practice & Research Clinical Gastroenterology.2015; 29(2): 309.     CrossRef
  • Impact of Radiofrequency Ablation on Malignant Biliary Strictures: Results of a Collaborative Registry
    Reem Z. Sharaiha, Amrita Sethi, Kristen R. Weaver, Tamas A. Gonda, Raj J. Shah, Norio Fukami, Prashant Kedia, Nikhil A. Kumta, Carlos M. Rondon Clavo, Michael D. Saunders, Jorge Cerecedo-Rodriguez, Paola Figueroa Barojas, Jessica L. Widmer, Monica Gaidhan
    Digestive Diseases and Sciences.2015; 60(7): 2164.     CrossRef
  • Randomised phase II trial of photodynamic therapy plus oral fluoropyrimidine, S-1, versus photodynamic therapy alone for unresectable hilar cholangiocarcinoma
    Do Hyun Park, Sang Soo Lee, So Eun Park, Jae Lyun Lee, Jun Ho Choi, Hee Jung Choi, Ji Woong Jang, Hyoung Jung Kim, Jun Bum Eum, Dong-Wan Seo, Sung Koo Lee, Myung-Hwan Kim, Jung Bok Lee
    European Journal of Cancer.2014; 50(7): 1259.     CrossRef
  • Is There Any Evidence for a Role of Local Treatment in Cholangiocarcinoma?
    Arndt Vogel, Oliver Dudeck
    Visceral Medicine.2014; 30(4): 254.     CrossRef
  • 6,632 View
  • 58 Download
  • 16 Crossref
Close layer

Clin Endosc : Clinical Endoscopy Twitter Facebook
Close layer
TOP